17 employees
Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults.
2021
$70M
from 3 investors over 3 rounds
Versanis Bio raised $70M on August 31, 2021
Investors: Medicxi, Atlas Venture and Aditum Bio